请输入您要查询的百科知识:

 

词条 Neutropenia
释义

  1. Signs and symptoms

  2. Causes

  3. Pathophysiology

  4. Diagnosis

     Classification 

  5. Treatment

  6. Prognosis

  7. Epidemiology

  8. See also

  9. References

  10. External links

{{use dmy dates|date=December 2017}}{{Infobox medical condition (new)
| name = Neutropenia
| synonyms =
| image = Neutropenia.JPG
| caption = Blood film with a striking absence of neutrophils, leaving only red blood cells and platelets
| pronounce =
| field = Infectious disease, Hematology
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes = Aplastic anemia, Glycogen storage disease, Cohen syndrome,[1][2] gene mutations
| risks =
| diagnosis = CBC[3]
| differential =
| prevention =
| treatment = Antibiotics, Splenectomy if needed,[3] G-CSF
| medication =
| prognosis =
| frequency =
| deaths =
}}Neutropenia is an abnormally low concentration of neutrophils (a type of white blood cell) in the blood.[1] Neutrophils make up the majority of circulating white blood cells and serve as the primary defense against infections by destroying bacteria, bacterial fragments and immunoglobulin-bound viruses in the blood.[2] People with neutropenia are more susceptible to bacterial infections and, without prompt medical attention, the condition may become life-threatening (neutropenic sepsis).[7]

Neutropenia can be divided into congenital and acquired, with severe congenital neutropenia (SCN) and cyclic neutropenia being autosomal dominant and mostly caused by heterzygous mutations in the ELANE gene (neutrophil elastase).[3] Neutropenia can be acute (temporary) or chronic (long lasting). The term is sometimes used interchangeably with "leukopenia" ("deficit in the number of white blood cells").[4]

Signs and symptoms

Signs and symptoms of neutropenia include fever, painful swallowing, gingival pain, skin abscesses, and otitis. These symptoms may exist because individuals with neutropenia often have infection.[5]

Children may show signs of irritability and poor feeding.[6] Additionally, hypotension has also been observed in individuals who suffer from this condition.[7]

{{clear}}

Causes

The causes of neutropenia can be divided between problems that are transient and those that are chronic. Causes can be divided into these groups:[1][7][8][9]

{{columns-list|colwidth=30em|
  • Chronic neutropenia:
    • Aplastic anemia
    • Felty syndrome
    • Systemic lupus erythematosus
    • HIV/AIDS infection
    • Glycogen storage disease
    • Cohen syndrome
    • Congenital immunological disorder, e.g. Kostmann syndrome, GATA2 deficiency
    • Barth syndrome
    • Vitamin B12 deficiency
    • Pearson syndrome
    • Pudlak syndrome
  • Transient neutropenia:
    • Typhoid
    • Tuberculosis
    • Cytomegalovirus
    • Propylthiouracil
    • Levamisole
    • Penicillamine
    • Trimethoprim/sulfamethoxazole
    • Clozapine
    • Valproate
    • Vaccination

}}

Gram-positive bacteria are present in 60–70% of bacterial infections. There are serious concerns regarding antibiotic-resistant organisms. These would include as methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE).[17])

Other causes of congenital neutropenia are Shwachman–Diamond syndrome, Cyclic neutropenia, bone marrow failure syndromes, cartilage–hair hypoplasia, reticular dysgenesis, and Barth syndrome. Viruses that infect neutrophil progenitors can also be the cause of neutropenia. Viruses identified that have an effect on neutrophils are rubella and cytomegalovirus.[1] Though the body can manufacture a normal level of neutrophils, in some cases the destruction of excessive numbers of neutrophils can lead to neutropenia. These are:[1]{{citation needed|date=October 2016}}

{{columns-list|colwidth=30em|
  • Bacterial or fungal sepsis
  • Necrotizing enterocolitis, circulating neutrophil population depleted due to migration into the intestines and peritoneum
  • Alloimmune neonatal neutropenia, the mother produces antibodies against fetal neutrophils
  • Inherited autoimmune neutropenia, the mother has autoimmune neutropenia
  • Autoimmune neutropenia of infancy, the sensitization to self-antigens

}}

Pathophysiology

The pathophysiology of neutropenia can be divided into congenital and acquired. The congenital neutropenia (severe and cyclic type) is autosomal dominant, with mutations in the ELA2 gene (neutrophil elastase) as the most common genetic reason for this condition.[3] Acquired neutropenia (immune-associated neutropenia) is due to anti-neutrophil antibodies that target neutrophil-specific antigens, ultimately altering neutrophil function.[10] Furthermore, emerging research suggests neutropenia without an identifiable etiology (idiopathic neutropenia) may be the result of a low-grade, chronic inflammatory process with an abnormal excessive production of myelosuppressive cytokines in a study conducted in the island of Crete.[11]

Neutropenia fever can complicate the treatment of cancers. Observations of children noted that fungal infections are more likely to develop in those with neutropenia. Mortality increases during cancer treatments if neutropenia is also present.[12]

Congenital neutropenia is determined by blood neutrophil counts (absolute neutrophil counts or ANC) < 0.5 × 10{{sup|9}}/L and recurrent bacterial infections beginning very early in childhood.[13]

Congenital neutropenia is related to alloimmunization, sepsis, maternal hypertension, twin-to-twin transfusion syndrome, and Rh hemolytic disease.[1]

Diagnosis

Neutropenia can be the result of a variety of consequences, including from certain types of drugs, environmental toxins, vitamin deficiencies, metabolic abnormalities, as well as cancer or infections. Neutropenia itself is a rare entity, but can be clinically common in oncology and immunocompromised individuals as a result of chemotherapy (drug-induced neutropenia). Additionally, acute neutropenia can be commonly seen from people recovering from a viral infection or in a post-viral state. Meanwhile, several subtypes of neutropenia exist which are rarer and chronic, including acquired (idiopathic) neutropenia, cyclic neutropenia, autoimmune neutropenia, and congenital neutropenia.{{medical citation needed|date=January 2018}}

Neutropenia that is developed in response to chemotherapy typically becomes evident in seven to fourteen days after treatment. Conditions that indicate the presence of neutropenic fever are implanted devices; leukemia induction; the compromise of mucosal, mucociliary and cutaneous barriers; a rapid decline in absolute neutrophil count, duration of neutropenia >7–10 days, and other illnesses that exist in the patient.[17]

Signs of infection can be subtle. Fevers are a common and early observation. Sometimes overlooked is the presence of hypothermia, which can be present in sepsis. Physical examination and accessing the history and physical examination is focussed on sites of infection. Indwelling line sites, areas of skin breakdown, sinuses, nasopharynx, bronchi and lungs, alimentary tract, and skin are assessed.[17]

The diagnosis of neutropenia is done via the low neutrophil count detection on a complete blood count. Generally, other investigations are required to arrive at the right diagnosis. When the diagnosis is uncertain, or serious causes are suspected, bone marrow biopsy may be necessary. Other investigations commonly performed: serial neutrophil counts for suspected cyclic neutropenia, tests for antineutrophil antibodies, autoantibody screen (and investigations for systemic lupus erythematosus), vitamin B12 and folate assays.[14][15] Rectal examinations are usually not performed due to the increased risk of introducing bacteria into the blood stream and the possible development of rectal abscesses. A routine chest X-ray and urinalysis may be can not be relied upon or considered normal due to the absence of neutrophils.[17]

Classification

Generally accepted reference range for absolute neutrophil count (ANC) in adults is 1500 to 8000 cells per microliter (µl) of blood. Three general guidelines are used to classify the severity of neutropenia based on the ANC (expressed below in cells/µl):[16]

  • Mild neutropenia (1000 <= ANC < 1500): minimal risk of infection
  • Moderate neutropenia (500 <= ANC < 1000): moderate risk of infection
  • Severe neutropenia (ANC < 500): severe risk of infection.

Each of these are either derived from laboratory tests or via the formula below:

ANC = [1][16][17]

Treatment

Recombinant granulocyte-colony stimulating factor preparations, such as filgrastim[18] can be effective in people with congenital forms of neutropenia including severe congenital neutropenia and cyclic neutropenia;[19] the amount needed (dosage) to stabilize the neutrophil count varies considerably (depending on the individual's condition).[20] Guidelines for neutropenia regarding diet are currently being studied.[21]

Most cases of neonatal neutropenia are temporary. Antibiotic prophylaxis is not recommended because of the possibility of encouraging the development of multidrug-resistant bacterial strains.[1]

Neutropenia can be treated with hematopoietic growth factors, granulocyte-colony stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF). These are cytokines (inflammation-inducing chemicals) that are present naturally in the body. These factors are used regularly in cancer treatment with adults and children. The factors promote neutrophil recovery following anticancer therapy.[1]

The administration of intravenous immunoglobulins (IVIGs) has had some success in treating neutropenias of alloimmune and autoimmune origins with a response rate of about 50%. Blood transfusions have not been effective.[1]

Prognosis

If left untreated, people with fever and absolute neutrophil count <500 have a mortality of up to 70% within 24 hours.[22] The prognosis of neutropenia depends on the cause. Antibiotic agents have improved the prognosis for individuals with severe neutropenia. Neutropenic fever in individuals treated for cancer has a mortality of 4-30%.[23]

Epidemiology

Neutropenia is usually detected shortly after birth, affecting 6% to 8% of all newborns in neonatal intensive care units (NICUs). Out of the approximately 600,000 neonates annually treated in NICUs in the United States, 48,000 may be diagnosed as neutropenic. The incidence of neutropenia is greater in premature infants. Six to fifty-eight percent of preterm neonates are diagnosed with this auto-immune disease. The incidence of neutropenia correlates with decreasing birth weight. The disorder is seen up to 38% in infants that weigh less than 1000g, 13% in infants weighing less than 2500g, and 3% of term infants weighing more than 2500 g. Neutropenia is often temporary, affecting most newborns in only first few days after birth. In others, it becomes more severe and chronic indicating a deficiency in innate immunity.[24]

Furthermore, the prevalence of chronic neutropenia in the general public is rare. In a study conducted in Denmark, over 370,000 people were assessed for the presence of neutropenia. Results published demonstrated only 1% of those evaluated were neutropenic, and were commonly seen in those suffering from HIV, viral infections, acute leukemias, and myelodsyplastic syndromes. The study concluded the presence of neutropenia is an ominous sign that warrants further investigation and follow-up.[25]

See also

  • Pancytopenia
  • Thrombocytopenia

References

1. ^{{Cite web|title = Neutropenia |publisher= National Center for Biotechnology, National Library of Medicine |url = https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0025031/ |accessdate = 2015-12-08}}
2. ^{{Cite web|title = Neutrophils |publisher= National Center for Biotechnology, National Library of Medicine |url = https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0022058/ |accessdate = 2015-12-08}}
3. ^{{Cite journal|title = ELANE Mutations in Cyclic and Severe Congenital Neutropenia|url = https://www.hemonc.theclinics.com/article/S0889-8588(12)00209-2/abstract|journal = Hematology/Oncology Clinics of North America|date = 2013|pages = 19–41|volume = 27|issue = 1|doi = 10.1016/j.hoc.2012.10.004|pmid = 23351986|pmc = 3559001|author=Marshall S. Horwitz|display-authors=etal|accessdate=2018-10-28}}
4. ^{{Cite journal|title = How to approach neutropenia|url = http://asheducationbook.hematologylibrary.org/content/2012/1/174|journal = ASH Education Program Book|date = 2012-12-08|issn = 1520-4391|pmid = 23233578|pages = 174–182|volume = 2012|issue = 1|doi = 10.1182/asheducation-2012.1.174|first = Laurence A.|last = Boxer|doi-broken-date = 2019-02-15}}
5. ^{{Cite web|title = Neutropenia Clinical Presentation: History, Physical Examination|url = http://emedicine.medscape.com/article/204821-clinical|website = emedicine.medscape.com|accessdate = 2015-12-08}}
6. ^{{Cite book|title = Nursing Care of the Critically Ill Child|url = https://books.google.com/books?id=up93BAm-wNoC&pg=PA835|publisher = Elsevier Health Sciences|date = 2012-05-04|page=835|isbn = 978-0323086035|first = Mary Fran|last = Hazinski}}
7. ^{{Cite journal|title = Evaluation and Management of Patients with Isolated Neutropenia|journal = Seminars in Hematology|date = 2013-07-01|issn = 0037-1963|pmc = 3748385|pmid = 23953336|pages = 198–206|volume = 50|issue = 3|doi = 10.1053/j.seminhematol.2013.06.010|first = Peter E.|last = Newburger|first2 = David C.|last2 = Dale}}
8. ^{{cite journal | vauthors = Donadieu J, Beaupain B, Fenneteau O, Bellanné-Chantelot C | title = Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history | journal = British Journal of Haematology | volume = 179 | issue = 4 | pages = 557–574 | date = November 2017 | pmid = 28875503 | doi = 10.1111/bjh.14887 | url = }}
9. ^{{cite journal |last1=Muturi-Kioi |first1=Vincent |last2=Lewis |first2=David |last3=Launay |first3=Odile |last4=Leroux-Roels |first4=Geert |last5=Anemona |first5=Alessandra |last6=Loulergue |first6=Pierre |last7=Bodinham |first7=Caroline L. |last8=Aerssens |first8=Annelies |last9=Groth |first9=Nicola |last10=Saul |first10=Allan |last11=Podda |first11=Audino |title=Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review |journal=PLoS ONE |date=4 August 2016 |volume=11 |issue=8 |pages=e0157385 |doi=10.1371/journal.pone.0157385 |pmid=27490698 |pmc=4974007 |issn=1932-6203|bibcode=2016PLoSO..1157385M }}
10. ^{{Cite journal|title = Neutropenia: etiology and pathogenesis|journal = Clinical Cornerstone|date = 2006-01-01|issn = 1098-3597|pmid = 17379162|pages = S5–11|volume = 8 Suppl 5|first = Lee S.|last = Schwartzberg|doi=10.1016/s1098-3597(06)80053-0}}{{Subscription or libraries|sentence|via=ScienceDirect}}
11. ^{{cite journal|last1=Dale|first1=David C.|last2=Bolyard|first2=Audrey Anna|title=An update on the diagnosis and treatment of chronic idiopathic neutropenia|journal=Current Opinion in Hematology|pages=46–53|doi=10.1097/MOH.0000000000000305|date=2017|pmid=27841775|pmc=5380401|volume=24|issue=1}}
12. ^{{cite journal|last1=Fredricks|first1=David N|last2=Fung|first2=Monica|last3=Kim|first3=Jane|last4=Marty|first4=Francisco M.|last5=Schwarzinger|first5=Michaël|last6=Koo|first6=Sophia|title=Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia|journal=PLOS ONE|volume=10|issue=11|year=2015|pages=e0140930|issn=1932-6203|doi=10.1371/journal.pone.0140930|pmid=26554923|pmc=4640557|bibcode=2015PLoSO..1040930F}}
13. ^{{cite journal|last1=Makaryan|first1=Vahagn|last2=Rosenthal|first2=Elisabeth A.|last3=Bolyard|first3=Audrey Anna|last4=Kelley|first4=Merideth L.|last5=Below|first5=Jennifer E.|last6=Bamshad|first6=Michael J.|last7=Bofferding|first7=Kathryn M.|last8=Smith|first8=Joshua D.|last9=Buckingham|first9=Kati|last10=Boxer|first10=Laurence A.|last11=Skokowa|first11=Julia|last12=Welte|first12=Karl|last13=Nickerson|first13=Deborah A.|last14=Jarvik|first14=Gail P.|last15=Dale|first15=David C.|title=TCIRG1-Associated Congenital Neutropenia|journal=Human Mutation|volume=35|issue=7|year=2014|pages=824–827|issn=1059-7794|doi=10.1002/humu.22563|pmid=24753205|pmc=4055522}}
14. ^{{cite book |author1=Levene, Malcolm I. |author2=Lewis, S. M. |author3=Bain, Barbara J. |author4=Imelda Bates |title=Dacie & Lewis Practical Haematology |publisher=W B Saunders |location=London |year= 2001|pages=586|isbn=978-0-443-06377-0 |oclc= }}
15. ^{{Cite web|title = Neutropenic Patients and Neutropenic Regimes {{!}} Patient|url = http://patient.info/doctor/neutropenic-patients-and-neutropenic-regimes|website = Patient|accessdate = 2015-12-08|language = en-GB}}
16. ^{{cite journal |vauthors=Hsieh MM, Everhart JE, Byrd-Holt DD, Tisdale JF, Rodgers GP |title=Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences |journal=Ann. Intern. Med. |volume=146 |issue=7 |pages=486–92 |date=April 2007 |pmid=17404350 |doi= 10.7326/0003-4819-146-7-200704030-00004|issn=0003-4819}}
17. ^{{Cite web|title = Absolute Neutrophil Count Calculator|url = http://reference.medscape.com/calculator/absolute-neutrophil-count|website = reference.medscape.com|accessdate = 2015-12-08}}
18. ^{{cite journal|last1=Schouten|first1=H. C.|title=Neutropenia management|journal=Annals of Oncology|date=3 October 2006|volume=17|issue=suppl 10|pages=x85–x89|doi=10.1093/annonc/mdl243|pmid=17018758|url=http://annonc.oxfordjournals.org/content/17/suppl_10/x85.full.pdf|accessdate=8 December 2015}}
19. ^{{Cite journal|title = The investigation and management of chronic neutropenia in children|journal = Archives of Disease in Childhood|date = 2006-10-01|issn = 0003-9888|pmc = 2066017|pmid = 16990357|pages = 852–858|volume = 91|issue = 10|doi = 10.1136/adc.2006.094706|first = R M|last = James|first2 = S E|last2 = Kinsey}}
20. ^{{Cite book|title = Agranulocytosis—Advances in Research and Treatment: 2012 Edition: ScholarlyBrief|url = https://books.google.com/books?id=SJl92M7dKQkC|publisher = ScholarlyEditions|date = 2012-12-26|page=95|isbn = 9781481602754}}
21. ^{{cite journal|last=Jubelirer|first=S. J.|title=The Benefit of the Neutropenic Diet: Fact or Fiction?|journal=The Oncologist|date=6 April 2011|volume=16|issue=5|pages=704–707|doi=10.1634/theoncologist.2011-0001|pmid=21471277|pmc=3228185}}
22. ^{{cite book | last = Williams | first = Mark | title = Comprehensive hospital medicine an evidence based approach | publisher = Saunders Elsevier | location = Philadelphia | year = 2007 | isbn = 978-1-4160-0223-9|postscript=; Access provided by the University of Pittsburgh }}
23. ^{{cite web|title=Neutropenia|url=http://emedicine.medscape.com/article/204821-overview#a12|website=eMedicine|publisher=MedScape|accessdate=8 December 2015}}
24. ^{{cite book | last = Ohls | first = Robin | title = Hematology, immunology and infectious disease neonatology questions and controversies | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2012 | isbn = 978-1-4377-2662-6 |postscript=: Access provided by the University of Pittsburgh}}
25. ^{{cite journal|last1=Andersen|first1=C. L.|last2=Tesfa|first2=D.|last3=Siersma|first3=V. D.|last4=Sandholdt|first4=H.|last5=Hasselbalch|first5=H.|last6=Bjerrum|first6=O. W.|last7=Felding|first7=P.|last8=Lind|first8=B.|last9=Olivarius|first9=Niels de F.|last10=Palmblad|first10=J.|title=Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study|journal=Journal of Internal Medicine|pages=566–575|doi=10.1111/joim.12467|date=2016|pmid=26791682|volume=279|issue=6}}

External links

{{Medical resources
| DiseasesDB = 8994
| ICD10 = {{ICD10|D|70||d|70}}
| ICD9 = {{ICD9|288.0}}
| ICDO =
| OMIM =
| MedlinePlus = 007230
| eMedicineSubj = med
| eMedicineTopic = 1640
| MeshID = D009503
}}{{Myeloid blood cells and plasma}}{{Monocyte and granulocyte disease}}{{Medicine}}

5 : Monocyte and granulocyte disorders|Blood|Blood disorders|Leukocytes|Autoimmune diseases

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/24 4:30:47